UK markets closed

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0001-0.0299 (-2.85%)
As of 02:05PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
33,250
34,071
28,674
24,100
18,849
-
Cost of revenue
16,962
17,444
15,185
12,742
9,066
-
Gross profit
16,288
16,627
13,489
11,358
9,783
-
Operating expenses
Research development
94
77
0
-
-
-
Selling general and administrative
38,546
39,127
35,870
37,209
18,117
-
Total operating expenses
38,640
39,204
35,870
37,209
18,117
-
Operating income or loss
-22,352
-22,577
-22,381
-25,851
-8,334
-
Interest expense
1,930
600
370
360
2,897
-
Total other income/expenses net
1,204
3,020
21,976
-11,462
280
-
Income before tax
-23,080
-20,117
-608
-37,657
-10,923
-
Income tax expense
10
14
32
56
64
-
Income from continuing operations
-23,090
-20,131
-640
-37,713
-10,987
-
Net income
-23,090
-20,131
-640
-37,713
-10,987
-
Net income available to common shareholders
-23,090
-20,131
-640
-37,713
-10,987
-
Basic EPS
-20.36
-
-0.61
-85.60
-18.94
-18.93
Diluted EPS
-20.36
-
-0.61
-85.60
-18.94
-18.93
Basic average shares
1,333
-
1,057
440.411
580
580
Diluted average shares
1,333
-
1,057
440.411
580
580